ConserV Bio partners with eTheRNA on mRNA vaccine development
Collaboration will focus on vaccines for infectious diseases
Read More
Tag: ConserV Bioscience
ConserV Bioscience to develop ‘broad-spectrum’ coronavirus vaccine
UK biotech company will collaborate with Lawrence Livermore National Laboratory
Read More
- NICE backs daratumumab quadruplet for newly diagnosed transplant‑ineligible myeloma
- Anocca doses first patients with precision TCR‑T therapy
- Connecta launches phase 2a trial of neuroplasticity modulator
- Aquipta recommended by NICE for acute migraine treatment
- Talvey accepted for use in Scotland for relapsed and refractory multiple myeloma
